Haemonetics Corp is a Healthcare company based in the United States, with a low-risk ESG score of 12.1. The company focuses on improving patient care and reducing healthcare costs by providing innovative medical solutions in the blood and plasma collection, surgical suite, and hospital transfusion sectors. Operating under three main segments - plasma, blood center, and hospital - Haemonetics Corp emphasizes its plasma and hospital divisions for their high growth potential. The company's revenue comes from the demand for disposable blood component collection sets and related equipment.